Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -5.76%120.23M | 1.39%261.08M | -0.42%127.57M | -4.17%257.5M | -0.37%128.1M | 1.21%268.72M | 2.64%128.58M | 3.61%265.5M | 6.70%125.27M | -7.11%256.27M |
| Operating income | -5.76%120.23M | 1.39%261.08M | -0.42%127.57M | -4.17%257.5M | -0.37%128.1M | 1.21%268.72M | 2.64%128.58M | 3.61%265.5M | 6.70%125.27M | -7.11%256.27M |
| Cost of sales | 11.15%-52.08M | 3.10%-117.89M | 3.07%-58.62M | 1.66%-121.66M | -3.78%-60.47M | -9.42%-123.72M | 0.77%-58.27M | -1.43%-113.07M | -13.82%-58.72M | 7.59%-111.48M |
| Operating expenses | 11.15%-52.08M | 3.10%-117.89M | 3.07%-58.62M | 1.66%-121.66M | -3.78%-60.47M | -9.42%-123.72M | 0.77%-58.27M | -1.43%-113.07M | -13.82%-58.72M | 7.59%-111.48M |
| Gross profit | -1.17%68.15M | 5.41%143.19M | 1.95%68.95M | -6.32%135.84M | -3.82%67.63M | -4.87%145M | 5.66%70.31M | 5.28%152.43M | 1.11%66.55M | -6.74%144.79M |
| Selling expenses | -2.62%-18.02M | -9.40%-37.66M | -8.15%-17.56M | -7.06%-34.42M | -1.74%-16.23M | 2.77%-32.15M | 3.36%-15.95M | -0.78%-33.07M | 0.51%-16.51M | 10.43%-32.81M |
| Administrative expenses | 10.67%-26.74M | 3.14%-60.93M | 6.93%-29.93M | -0.67%-62.91M | -5.81%-32.16M | -3.07%-62.49M | -9.43%-30.4M | 0.46%-60.63M | 0.52%-27.78M | 4.02%-60.91M |
| Depreciation and amortization | 3.36%-6.45M | ---- | ---6.67M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus | ---- | -70.82%-5.28M | ---- | -28.15%-3.09M | 69.62%-501K | -463.80%-2.41M | -232.88%-1.65M | 117.94%663K | 130.12%1.24M | -193.59%-3.7M |
| -Changes in the fair value of investment property | ---- | -167.09%-5M | ---- | -2,240.00%-1.87M | ---- | -116.00%-80K | -116.00%-80K | 153.13%500K | 135.09%500K | -125.95%-941K |
| -Changes in the fair value of financial assets | ---- | 77.03%-280K | ---- | 47.73%-1.22M | 68.07%-501K | -1,530.67%-2.33M | -311.74%-1.57M | 105.92%163K | 127.50%741K | -952.94%-2.76M |
| Impairment and provision | 126.90%106K | ---- | ---394K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | 126.90%106K | ---- | ---394K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating interest expense | -32.88%-582K | ---- | ---438K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items of operating profit | 205.64%1.25M | -80.77%544K | -69.55%408K | -6.26%2.83M | -43.22%1.34M | 368.27%3.02M | 380.95%2.36M | -107.01%-1.13M | -131.69%-840K | 766.88%16.05M |
| Operating profit | 23.29%17.71M | 4.21%39.86M | -28.43%14.37M | -24.95%38.25M | -18.64%20.08M | -12.55%50.96M | 8.87%24.67M | -8.11%58.28M | 14.27%22.66M | 4.02%63.42M |
| Financing cost | ---- | -131.98%-1.09M | ---- | -18.14%-469K | 2.05%-191K | -62.04%-397K | 68.14%-195K | 78.79%-245K | -61.90%-612K | -4.81%-1.16M |
| Special items of earning before tax | -40.38%3.81M | 27,650.00%555K | 24,700.00%6.4M | -99.77%2K | -105.17%-26K | 314.89%866K | 294.21%503K | 35.52%-403K | -149.04%-259K | -286.57%-625K |
| Earning before tax | 3.67%21.53M | 4.09%39.33M | 4.56%20.76M | -26.54%37.78M | -20.51%19.86M | -10.75%51.43M | 14.63%24.98M | -6.51%57.63M | 12.61%21.79M | 2.39%61.64M |
| Tax | -9.11%-2.97M | -129.78%-10.43M | -46.84%-2.72M | -1.63%-4.54M | 41.29%-1.85M | 3.60%-4.47M | -495.47%-3.16M | -168.48%-4.63M | -206.43%-530K | 59.94%-1.73M |
| After-tax profit from continuing operations | 2.85%18.56M | -13.08%28.9M | 0.21%18.04M | -29.22%33.24M | -17.50%18.01M | -11.38%46.97M | 2.65%21.83M | -11.55%52.99M | 7.12%21.26M | 7.19%59.91M |
| Earning after tax | 2.85%18.56M | -13.08%28.9M | 0.21%18.04M | -29.22%33.24M | -17.50%18.01M | -11.38%46.97M | 2.65%21.83M | -11.55%52.99M | 7.12%21.26M | 7.19%59.91M |
| Minority profit | 69.92%-37K | -57.94%-169K | 46.75%-123K | -132.61%-107K | -234.78%-231K | 94.59%-46K | 45.67%-69K | -303.32%-851K | ---127K | ---211K |
| Profit attributable to shareholders | 2.36%18.6M | -12.85%29.07M | -0.39%18.17M | -29.06%33.35M | -16.71%18.24M | -12.69%47.01M | 2.36%21.9M | -10.45%53.84M | 7.76%21.39M | 7.57%60.13M |
| Basic earnings per share | 2.68%0.0766 | -11.48%0.1195 | 1.08%0.0746 | -29.02%0.135 | -16.70%0.0738 | -12.59%0.1902 | 2.55%0.0886 | -10.49%0.2176 | 7.60%0.0864 | 7.42%0.2431 |
| Diluted earnings per share | 2.96%0.0764 | -11.46%0.119 | 0.95%0.0742 | -29.04%0.1344 | -16.67%0.0735 | -12.60%0.1894 | 2.56%0.0882 | -10.42%0.2167 | 7.63%0.086 | 7.56%0.2419 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young Accounting Firm | -- | Ernst & Young Accounting Firm | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.